Description
Added on the 19/03/2021 18:22:42 - Copyright : AFPTV - First images
The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits still outweigh the risks for adults despite links to blood clots. SOUNDBITE
Europe's medicines regulator says that blood clots should be listed as a very rare side effect of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweigh the risks. SOUNDBITE
Head of Vaccine Strategy at the European Medicines Agency (EMA) Marco Cavaleri says it is "safe and effective" to issue booster doses of Covid-19 vaccines as soon as three months after the initial course, down from previous guidance of six months. SOUNDBITE
Staff at a vaccine centre in a Bangalore hospital create a colourful floor display to mark India administering its one billionth Covid-19 vaccine dose on Thursday. About three-quarters of adults in the country of 1.3 billion people have had one shot and 30 percent are fully vaccinated, according to government figures. IMAGES
A member of a British government committee advising on coronavirus vaccinations says during a press conference that most people under 30 should be offered an alternative to the AstraZeneca jab if possible, due to concerns over blood clots. SOUNDBITE
|
Support : Technical 
- Content 
- Editors 
